Research and Development of Ad26. ZEBOV

Awarded Award Notice Posted

Solicitation number
CBRN-BAA-13-100-SOL-00013
Agency
Immediate Office of the Secretary Department of Health and Human Services
Awarded
to Janssen Vaccines & Prevention B.V.
Set-aside
No set-aside

Opportunity facts

Contract number
HHSO100201500008C Federal contract award
NAICS code
541711 Research and Development in Biotechnology
PSC
Not on record

Notice details come from SAM.gov. Updated .

Notice text

Added: Sep 10, 2015 7:25 pm Award of a Total Estimated Cost Plus Fixed Fee (CPFF) contract to Crucell Holland, B.V. (a Janssen Pharmaceutical Company) for the research and development of Ad26.ZEBOV.

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
Clinical development of Ceftobiprole Latest Award Notice
Development of a Single Dose Intranasal Post-Exposure Prophylaxis Vaccine for Inhalation Anthrax Award Notice
Research and Development of Ad26. ZEBOV This notice Award Notice
Advanced Research and Development of NuThrax or AV7909 Award Notice

And 1 more award notice.

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity